Micron- and MicroStrategy-Leveraged ETFs Plunge Over 18%–33%, Biotech Stocks Also Fall 23%
DSC•Leveraged ETFs tied to Micron and MicroStrategy plunged 33.28% and 18.65% today, driving sharp losses in semiconductor and tech-related funds. Biotech stocks IceCure and ARS Pharmaceuticals also tumbled over 23%, underscoring broad market weakness that could pressure DSC’s share performance.
1. Broad ETF Pullback
The Defiance Daily Target 2X Short MU ETF fell 33.28% to $9.08 as traders unwound bets against Micron Technology, while the Daily Target 2X Long MSTR ETF dropped 18.65% to $7.33 amid a sell-off in MicroStrategy shares, amplifying losses for leveraged investors.
2. Healthcare Stocks Slide
IceCure Medical shares declined 24.52% to $7.02 despite regaining Nasdaq compliance, and ARS Pharmaceuticals shares fell 23.91% to $8.02 after failing to secure additional insurance coverage for its Neffy allergy spray, highlighting sector-specific headwinds.
3. Potential Impact on DSC
DSC’s stock could face downward pressure as broad selling in semiconductors, tech and biotech fuels risk aversion; weakness in leveraged ETFs and small-cap healthcare names may signal reduced appetite for DSC’s market segment.
